LaNova Medicines Zhejiang Co., Ltd.
Quick facts
Phase 3 pipeline
- LM-302 Injection · Oncology
LM-302 Injection is a monoclonal antibody targeting a specific molecular target.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
- LaNova Medicines Zhejiang Co., Ltd. portfolio CI brief
- LaNova Medicines Zhejiang Co., Ltd. pipeline updates RSS
Frequently asked questions about LaNova Medicines Zhejiang Co., Ltd.
What is LaNova Medicines Zhejiang Co., Ltd.'s pipeline?
LaNova Medicines Zhejiang Co., Ltd. has 1 drugs in Phase 3, 0 in Phase 2, 0 in Phase 1. Late-stage candidates include LM-302 Injection.
Related
- Sector hub: All tracked pharma companies